Reported Jan 17, 2024 · Ongoing
CD11b APC: ASR, REF: 340936, and CE, REF: 333143
Becton, Dickinson and Company, BD Biosciences
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Becton, Dickinson and Company, BD Biosciences · 2350 Qume Dr · San Jose, CA · 95131-1812
Is this the product you have?
- CD11b APCASR
- REF340936, and CE
- REF333143
- Lot codes and dates
2 of 2 products · 2 lot codes
Recalled lot codes, grouped by product number REF UDI-DI Expiration 3409360038290340936520250228
3331430038290333143720250228
- Amount recalled
- 464 Vials
Where it was sold
Why it was recalled
In vitro diagnostics product that impacts the quality of cell staining can cause low or dim fluorescence signal, which can lead to potential false negative results and misdiagnosis of hematological malignancy, delayed treatment, and the need for additional patient samples.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Becton, Dickinson and Company, BD Biosciences recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.